|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 16/09/14 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 04/09/14 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 01/04/2002 | |
Carla Fiankan
LAW | General Counsel | - | 01/08/2011 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | -1.48% | -1.34% | +14.07% | 46.86B | |
| -0.61% | +1.03% | +396.16% | +643.07% | 40.23B | |
| 0.00% | +4.45% | +11.81% | +60.81% | 36.23B | |
| +2.48% | +3.37% | +7.05% | -8.08% | 34.72B | |
| +0.62% | +1.65% | +5.41% | +43.89% | 27.89B | |
| -2.00% | +9.60% | +31.71% | +129.76% | 16.79B | |
| -0.17% | -2.90% | - | - | 16.74B | |
| +0.78% | -4.78% | -2.68% | +9.96% | 13.12B | |
| +1.82% | -0.72% | -9.75% | -33.31% | 12.7B | |
| Average | +0.56% | +0.97% | +54.80% | +107.52% | 27.25B | |
| Weighted average by Cap. | +0.71% | +1.05% | +74.70% | +138.10% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
